CMV drug approved.
D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D016867:Immunocompromised Host; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D015774:Ganciclovir